Work Ability in Young Adult Cancer Survivors

Status Completed

Clinical Trial Summary

To document levels of labor force participation, occupation, educational attainment, and financial toxicity following cancer treatment in YA cancer survivors aged 25-34 years.

Clinical Trial Description

This observational, cross-sectional study will recruit 220 analyzable YA survivors through the Wake Forest National Cancer Institute Community Oncology Research Program (NCORP) Research Base (WF NCORP RB). Data will be collected using a web-based interface and will capture physical, psychosocial and cognitive late effects; work ability; work-related outcomes, including labor force participation, occupation, work place characteristics, and educational attainment; survivor characteristics; and cancer diagnosis/treatment information (from clinical records). We will evaluate the relationships among these measures using the theoretical framework to guide statistical analysis. ;

Study Design

Related Conditions & MeSH terms

Cancer Survivor

Clinical Trial Details

NCT number	NCT03148080
Study type	Observational
Source	Wake Forest University Health Sciences
Contact
Status	Completed
Phase
Start date	March 13, 2018
Completion date	July 29, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02235051` - Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors	N/A
Completed	`NCT01439945` - Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer	Phase 2
Active, not recruiting	`NCT02194387` - Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members	N/A
Completed	`NCT01641068` - Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms	N/A
Not yet recruiting	`NCT05403671` - Fit for Everyday Life - Increasing Exercise and Physical Activity in Those Rehablilitating From Cancer	N/A
Completed	`NCT00246818` - Effect of Tai Chi Vs. Structured Exercise on Physical Fitness and Stress in Cancer Survivors	Phase 2
Completed	`NCT02559557` - Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive Effects	N/A
Completed	`NCT00956475` - Quality of Life in Younger Leukemia and Lymphoma Survivors	Phase 1
Completed	`NCT02032121` - Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors	N/A
Completed	`NCT00932997` - Survivorship Booklets With or Without Individual Telephone Sessions in Increasing Knowledge About the Impact of Breast Cancer in African American and Latina Breast Cancer Survivors	N/A
Completed	`NCT02566408` - Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical Activity	N/A
Completed	`NCT02985411` - Harvest for Health in Older Cancer Survivors	N/A
Completed	`NCT00915889` - Psychosocial Support for African-American, Latina-American, or European-American Cervical Cancer Survivors	N/A
Completed	`NCT02518308` - Mindfulness Intervention in Reducing Anxiety in Patients Who Have Been Treated for Gynecologic Cancer	N/A
Completed	`NCT03307044` - Fractional CO2 Laser Therapy for Survivors of Breast Malignancies	N/A
Terminated	`NCT03781778` - Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors	Phase 2
Completed	`NCT02613364` - Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy in Reducing Insomnia in Cancer Survivors	N/A
Completed	`NCT03520283` - Systems Support Mapping in Guiding Self-Management in Stage I-III Colorectal Cancer Survivors	N/A
Completed	`NCT02662335` - Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors	N/A
Active, not recruiting	`NCT01347970` - Pharmacologic Reversal of Ventricular Remodeling in Childhood Cancer Survivors at Risk for Congestive Heart Failure (PREVENT-CHF): A Phase IIB Randomized Placebo-Controlled Trial	Phase 2